Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009 and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017. The company was founded in 2009 by Arie Belldegrun, an Israeli-American oncologist, who served as the company's chairman, president and chief executive officer. Belldegrun had a co-founder in Joshua Kazam, who took on the role of Director. More information...
According to PR-model, kitepharma.com is ranked 563,742nd in multilingual Wikipedia, in particular this website is ranked 325,302nd in English Wikipedia.
The website is placed before sombom.com.br and after hengst.com in the BestRef global ranking of the most important sources of Wikipedia.
